Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developments in L2-based human papillomavirus (HPV) vaccines

23 Nov 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Immunotherapy and Immune Responses
Share to Microbial infections and disease research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27889616
DOI: 10.1016/j.virusres.2016.11.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developments in L2-based human papillomavirus (HPV) vaccinesPMID 27889616Read ↗

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?Semantic proximity Read ↗

Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated DiseasesSemantic proximity Read ↗

Chapter 12: Human Papillomavirus TechnologiesSemantic proximity Read ↗

Human papilloma viruses and cancer in the post-vaccine eraSemantic proximity Read ↗

In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccineSemantic proximity Read ↗

Human Papillomavirus: An Old New HistorySemantic proximity Read ↗

Papillomavirus Prophylactic Vaccines: Established Successes, New ApproachesSemantic proximity Read ↗

Potential of Recombinant Chimeric HPV16 L1/L2 VLPs Produced by Distinct Cell Lineages Such as Prophylactic Nanovaccine and Therapeutic Drug NanocarriersSemantic proximity Read ↗

Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccinesSemantic proximity Read ↗

Human papillomavirus: current status and issues of vaccinationSemantic proximity Read ↗

Human Papillomavirus: Challenges and Opportunities for the Control of Cervical CancerSemantic proximity Read ↗

In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human PapillomavirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.